1. Metabolic Enzyme/Protease
  2. Phosphatase
  3. PFKFB3-IN-3

PFKFB3-IN-3 is a selective PFKFB3 inhibitor with a Ki value of 0.09 μM. PFKFB3-IN-3 reduces cancer cell viability, inhibits tumor growth in xenograft models, and acts as a chemosensitizer to exert synergistic effects with chemotherapeutic agents. The limited cellular activity of PFKFB3-IN-3 restricts its application as a chemical probe, but it demonstrates that the Cys154 residue of PFKFB3 is druggable. PFKFB3-IN-3 can be used for the research of pancreatic ductal adenocarcinoma.

For research use only. We do not sell to patients.

PFKFB3-IN-3

PFKFB3-IN-3 Chemical Structure

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

PFKFB3-IN-3 is a selective PFKFB3 inhibitor with a Ki value of 0.09 μM. PFKFB3-IN-3 reduces cancer cell viability, inhibits tumor growth in xenograft models, and acts as a chemosensitizer to exert synergistic effects with chemotherapeutic agents. The limited cellular activity of PFKFB3-IN-3 restricts its application as a chemical probe, but it demonstrates that the Cys154 residue of PFKFB3 is druggable. PFKFB3-IN-3 can be used for the research of pancreatic ductal adenocarcinoma[1].

In Vitro

PFKFB3-IN-3 (Compound 6) (1-50 μM; 48 h) reduces the viability of pancreatic ductal adenocarcinoma (PDAC) cell lines (PANC-1, MIA PaCa-2, Suit2, AsPC1, PaCa3, Hs776T), whereas its cytotoxicity against NHDF and HPDE cells is negligible[1].
PFKFB3-IN-3 (25 μM; 15 min-4 h) induces sustained cytotoxicity in PANC-1 and MIA PaCa-2 PDAC cells following transient exposure (1 h and longer)[1].
PFKFB3-IN-3 (1-50 μM; 48 h) reduces the viability of human cancer cell lines with high PFKFB3 expression (A549, ACHN, U251, SH-SY5Y) derived from non-pancreatic ductal adenocarcinoma (non-PDAC), while exerting minimal effects on PFKFB3-negative non-transformed fibroblasts (BJ, WI-38)[1].
PFKFB3-IN-3 (25 μM; 2 h) reduces PFK activity in lysates of MIA PaCa-2 PDAC cells, confirming that it continuously inhibits glycolytic flux via covalent targeting of PFKFB3[1].
PFKFB3-IN-3 (25 μM; 1-2 h) rapidly and potently blocks glycolytic ATP production in MIA PaCa-2 pancreatic ductal adenocarcinoma cells[1].
PFKFB3-IN-3 (25 μM; 2-6 h) reduces the glycolysis rate, glycolytic capacity, and glycolytic reserve of PANC-1 and MIA PaCa-2 PDAC cells, and its inhibitory effect on glycolytic function is time-dependent[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay[1]

Cell Line: Normal human dermal fibroblasts (NHDF), immortalized pancreatic ductal epithelial cells (HPDE), human PDAC cell lines (PANC-1, MIA PaCa-2, Suit2, AsPC1, PaCa3, Hs776T)
Concentration: 1, 10, 25 and 50 μM
Incubation Time: 48 h
Result: Showed no cytotoxicity in NHDF cells at concentrations up to 50 μM.
Showed minimal cytotoxicity in HPDE cells.
Induced dose-dependent cytotoxicity across all PDAC cell lines, with IC50 values ranging from 15 to 30 μM depending on the cell line.

Cell Viability Assay[1]

Cell Line: PANC-1, MIA PaCa-2 PDAC cell lines
Concentration: 25 μM
Incubation Time: 15 min, 1, 2, 3, or 4 h
Result: Impaired long-term cell viability significantly in both cell lines after a 1 h incubation.
Increased cytotoxic effects with longer incubation times.
In Vivo

PFKFB3-IN-3 (Compound 6) (7 μM; waterborne exposure; 48 h) exerts statistically significant anti-tumor effects in a zebrafish PDAC xenograft model, and its ability to reduce signals from fluorescently labeled tumor cells is superior to the baseline clearance level[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: 2 days post-fertilization embryos[1]
Dosage: 7 μM
Administration: immersion in fish water; daily; 48 h
Result: Reduced fluorescence intensity statistically significantly at T2 compared to controls in MIA PaCa-2 xenografts.
Reduced fluorescence intensity statistically significantly at both T1 and T2 compared to controls in PANC-1 xenografts, with more pronounced and significant reduction at T2.
Molecular Weight

506.00

Formula

C27H28ClN5O3

SMILES

C/C=C\C(N1C=C(C2=CC(OC3=CC=C(C=C3)NC([C@@H]4CCCN4)=O)=CC=C21)C5=CN(N=C5)C)=O.Cl

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
PFKFB3-IN-3
Cat. No.:
HY-184148
Quantity:
MCE Japan Authorized Agent: